Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
Show more...
FAQ
Silk Road Medical 的股票代码是什么?▼
根据交易所不同,股票代码可能会有所不同。例如,在 Boerse Stuttgart 交易所,Silk Road Medical 的股票以代码 2OW.STU 进行交易。
Silk Road Medical 有多少名员工?▼
截至七月 11, 2026,公司共有474名员工。
Silk Road Medical 属于哪个行业?▼
Silk Road Medical从事于制造业行业。
Silk Road Medical 何时完成拆股?▼
Silk Road Medical 最近没有进行任何拆股。
Silk Road Medical 的总部在哪里?▼
Silk Road Medical 的总部位于 美国 的 Sunnyvale。